EUVIMEDEUVIMED entdecken
Crossref

Clinical Outcomes of Mitral Regurgitation Severity and Transcatheter Edge‐to‐Edge Repair in Atrial Functional Mitral Regurgitation

Jwan A Naser iD, Faysal Massad, Christopher G Scott, Barry A Borlaug iD, Hector I Michelena, Trevor J Simard iD, Konstantinos C Siontis, Austin M Kennedy, Jeremy J Thaden, Patricia A Pellikka, Vuyisile T Nkomo, Mackram F Eleid iD und 1 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Jwan A Naser und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Cardiac Catheterization, Mitral Valve, Heart Valve Prosthesis Implantation. Die Arbeit nennt 29 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Incident atrial functional mitral regurgitation (AFMR) is associated with mortality. Transcatheter edge‐to‐edge repair (TEER) has shown effectiveness in improving MR and symptoms in AFMR, but previous studies lacked comparison to conservative management. We aimed to study the association of AFMR severity and mitral TEER with symptoms, heart failure hospitalizations (HFH) and all‐cause mortality in moderate/severe AFMR.

Methods

Consecutive adults with moderate/severe AFMR managed conservatively or with TEER 2010−2023 were identified retrospectively. To ensure similar technique in evaluation in the two groups, variables were obtained from the closest transthoracic echocardiogram before TEER in the TEER group. In addition to multivariable analysis, the association of TEER (vs. conservative management) with HFH and mortality was assessed using propensity‐score matched analyses; the propensity score was based on age, sex, EuroSCORE II, effective regurgitant orifice area, integrative MR severity, and NYHA class III/IV (vs. I/II).

Results

Among 230 patients with moderate/severe AFMR [mean age 77; 56% females], 46 were managed with TEER. Severe (vs. moderate) AFMR was independently associated with baseline NYHA class III/IV (multivariable OR 2.18 [95% CI 1.13−4.26]) and HFH [multivariable HR 2.75 (95% CI 1.25−6.03)] but not mortality ( p = 0.26). TEER improved MR to ≤ moderate in 93% but was not associated with lower HFH or death rates versus conservative management on multivariable or matched analysis. However, 1‐year NYHA improved more with TEER versus conservative management in patients with baseline NYHA class III/IV (62% vs. 27%, p = 0.03). Rhythm control was associated with improved survival (HR 0.38 [0.15−0.98]).

Conclusions

AFMR severity was associated with symptoms and HFH but not mortality. MR severity and NYHA class improved with TEER, but the association of TEER with HF hospitalizations or death remains unproven. Randomized studies are needed to evaluate the potential role of TEER and rhythm control on outcomes in AFMR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyCardiac CatheterizationMitral ValveHeart Valve Prosthesis ImplantationHumansFemaleMaleSeverity of Illness IndexRetrospective StudiesTreatment OutcomeAgedRisk FactorsTime FactorsAged, 80 and overRisk AssessmentRecovery of FunctionHeart FailureConservative Treatment

Stichwörter der Autor:innen

echocardiographyedge‐to‐edge repairheart failuremitral regurgitationmortalitytranscatheter intervention

Autor:innen und Institutionen

  • The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • The Department of Quantitative Health Sciences and Biostatistics, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Jwan A Naser, Barry A Borlaug, Trevor J Simard, Mackram F Eleid

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Naser, J. A., Massad, F., Scott, C. G., Borlaug, B. A., Michelena, H. I., Simard, T. J., Siontis, K. C., Kennedy, A. M., Thaden, J. J., Pellikka, P. A., Nkomo, V. T., Eleid, M. F., & Pislaru, S. V. (2025). Clinical Outcomes of Mitral Regurgitation Severity and Transcatheter Edge‐to‐Edge Repair in Atrial Functional Mitral Regurgitation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31567

Vancouver

Naser JA, Massad F, Scott CG, Borlaug BA, Michelena HI, Simard TJ, et al. Clinical Outcomes of Mitral Regurgitation Severity and Transcatheter Edge‐to‐Edge Repair in Atrial Functional Mitral Regurgitation. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31567

BibTeX
@article{Naser2025,
  author = {Naser, Jwan A and Massad, Faysal and Scott, Christopher G and Borlaug, Barry A and Michelena, Hector I and Simard, Trevor J and Siontis, Konstantinos C and Kennedy, Austin M and Thaden, Jeremy J and Pellikka, Patricia A and Nkomo, Vuyisile T and Eleid, Mackram F and Pislaru, Sorin V},
  title = {Clinical Outcomes of Mitral Regurgitation Severity and Transcatheter Edge‐to‐Edge Repair in Atrial Functional Mitral Regurgitation},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31567}
}
Kostenlos starten →